於2025年2月17日召開的2025年第一次臨時股東大會上，本公司通過了股東大會 對本公司董事會（「董事會」）的授權方案的修訂，據此，股東大會授權董事會發行 債務融資工具，發行規模合計不超過本公司最近一期經審計淨資產的350%。 董事會欣然宣佈，根據上述股東授權，本公司已於2025年8月21日完成2025年度 第二十期短期融資券發行（「本期融資券」）。本期融資券的發行規模為人民幣40億 元，面值及發行價均為每單位人民幣100元。本期融資券的期限為85天，最終票 面利率為1.64%。本期融資券發行所募集的資金將用於補充本公司流動資金。 承董事會命 中國銀河證券股份有限公司 王晟 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致之任何損失承擔任何責任。 （在中華人民共和國註冊成立之股份有限公司） （股份代號：06881） 公告 2025年度第二十期短期融資券發行完畢 茲提述中國銀河證券股份有限公司（「本公司」）日期為2025年1月23日的通函以及 2025年2月17日之公告。 董 ...

Core Insights - The report highlights that the equity market has reached new highs, with strong performance from high volatility strategies [1] - The report provides updates on convertible bond quantitative strategies, including low-price enhancement, improved dual-low, and high-price high-elasticity strategies, showcasing their respective performances and adjustments [2][3] Group 1: Strategy Performance and Recommendations - The low-price enhancement strategy recorded a performance of 3.5% during the last period (8.5-8.18), while the improved dual-low strategy and high-price high-elasticity strategy achieved 3% and 6.8% respectively, against a benchmark of 4% [2] - Year-to-date performances for these strategies are 13.5%, 26.4%, and 48.5%, respectively, with significant excess returns of -2.2%, 10.7%, and 32.8% compared to the benchmark of 15.7% [2] - The report notes that the equity market saw a rapid rise, with the Shanghai Composite Index surpassing 3700 points, and the Wande All A and Zhongzheng convertible bonds increasing by 5.6% and 4% respectively [2] Group 2: Low-Price Enhancement Strategy - The latest holdings for the low-price enhancement strategy include newly added convertible bonds such as Muyuan Convertible Bond (Agriculture), Hangyang Convertible Bond (Basic Chemicals), and Huayuan Convertible Bond (Pharmaceuticals) [2][10] - The rationale for adjustments in the low-price enhancement strategy is based on the rapid rise in the equity market, with a focus on companies showing growth in interim reports [2][10] Group 3: Improved Dual-Low Strategy - The improved dual-low strategy's latest holdings include new entries like Baichuan Convertible Bond (Basic Chemicals) and Jintian Convertible Bond (Non-ferrous Metals) [2][18] - Adjustments were made due to the dual-low style index's weaker performance compared to the benchmark, with a focus on companies with good interim performance [2][20] Group 4: High-Price High-Elasticity Strategy - The high-price high-elasticity strategy has seen a performance of 6.77% in the last period, significantly outperforming the benchmark [26] - Year-to-date performance for this strategy stands at 48.52%, with an excess return of 32.82% compared to the benchmark [26] - The strategy focuses on high-priced, low-premium convertible bonds, with adjustments made to maintain a balanced industry allocation [22][26]

Core Viewpoint - The Guangdong Provincial Government has issued policies to promote high-quality development in commercial aerospace from 2025 to 2028, focusing on satellite internet applications and government procurement support for domestic satellite data applications [1] Group 1: Policy Support and Industry Expansion - The document emphasizes the creation of major application scenarios for commercial aerospace, accelerating satellite internet services in various fields such as low-altitude economy, mobile communication, logistics, smart cities, space mining, space tourism, and emergency rescue [2] - Government procurement will be enhanced for typical benchmark cases and innovative products, encouraging industries to purchase domestic satellite-related data and products [2] - Local governments are encouraged to reward enterprises that expand satellite application industries and purchase computing power services [2] Group 2: Positive Industry Trends - The central economic meeting in 2023 categorized the low-altitude economy as a strategic emerging industry, further emphasizing the importance of commercial aerospace and low-altitude economy in the 2024 government work report [3] - Various provinces and cities, including Sichuan, Beijing, Shanghai, and Wuhan, have introduced related documents or action plans, reflecting local governments' commitment to satellite internet and commercial aerospace [3] - The urgency of low-orbit space resource deployment is increasing, with China's large satellite constellations like Xingwang and Qianfan being planned [3] Group 3: Application Scenarios and Market Growth - Key technologies such as reusable rockets, low-cost satellites, and inter-satellite links are making breakthroughs, leading to a predicted peak period for China's commercial aerospace in the next three years [4] - The cost of transportation is expected to drop below 30,000 yuan per kilogram, approaching the capabilities of overseas competitors [4] - The demand for low-altitude economy and space tourism is expected to grow, with significant breakthroughs in urban air traffic, industrial applications, and agricultural production [4]

Group 1 - The core viewpoint of the report is that XJ Electric (000400.SZ, latest price: 23.28 CNY) is given a recommended rating due to its strong performance in the ultra-high voltage sector, which is expected to continue benefiting from sustained demand [2] - The domestic market position of XJ Electric remains strong, indicating a leading status in the industry [2] - The international market shows robust growth potential for XJ Electric, contributing to its overall positive outlook [2] - The company's profitability is on a continuous upward trend, reinforcing its financial health and investment appeal [2]

Market Overview - The A-share market experienced a sudden decline in the afternoon, with the Shanghai Composite Index dropping over 0.2% before recovering slightly, while the Shenzhen Component and ChiNext indices fell [2] - The trading volume in the Shanghai and Shenzhen markets exceeded 2 trillion yuan for the first time this year, marking the seventh consecutive trading day of such volume [2] Sector Performance - Securities stocks collectively faced a pullback, with notable declines including Changcheng Securities down over 6% and Hato Securities down over 5% [2][3] - Several high-priced stocks hit the daily limit down, including Lianhuan Pharmaceutical and Zhongdian Xindong, with others like Shunlian Bio and Sainuo Medical dropping over 8% [4] Banking Sector - In contrast, bank stocks showed strength in the afternoon, with Agricultural Bank of China and Postal Savings Bank reaching new historical highs during the session [2] Hong Kong Market - The Hang Seng Index fell over 0.5%, and the Hang Seng Tech Index dropped more than 1% [6] - AAC Technologies Holdings (02018.HK) saw a rapid decline of over 14% following the release of its interim results, despite reporting a revenue of 13.32 billion yuan, a year-on-year increase of 18.4% [6][8] Company Performance - AAC Technologies reported a gross margin of 20.7%, down 0.8 percentage points year-on-year, attributed to changes in product mix, while net profit attributable to shareholders increased by 63.1% to 876 million yuan due to improved profitability in optical business and rapid growth in precision structural components [8] - CICC noted that the overall valuation level of A-shares remains reasonable, but the rapid increase in trading volume may lead to short-term volatility [8]

Group 1 - The complexity of hematological tumors presents numerous investment opportunities in various subtypes of treatment [1] - The market for hematological tumors is expanding due to innovative therapies, with significant product launches expected [1] - The number of long-term patients is increasing, with approximately 4 million patients globally having survived five years or more as of 2022, which is three times the number of new patients [1] Group 2 - Future development directions for hematological tumor treatment include improving efficacy, reducing recurrence, and optimizing administration [2] - Acute leukemias like AML and ALL primarily use chemotherapy or targeted combination therapies to enhance survival rates [2] - CAR-T therapy shows high remission rates for aggressive lymphomas and multiple myeloma, providing more treatment options for patients [2] Group 3 - The competition in the targeted drug market for hematological tumors has entered a new phase, with a focus on technological iterations and exploration of new targets [3] - In the BTK field, new products are emerging to compete in the post-resistance market, with Zebutinib outperforming Ibrutinib [3] - The BCL-2 domain is seeing advancements with differentiated designs and optimized dosing strategies to gain competitive advantages [3]

Core Viewpoint - Company released its 2025 semi-annual report, showing a revenue of 111 million yuan, a year-on-year increase of 18.44%, and a net profit attributable to shareholders of 6.3153 million yuan, a year-on-year increase of 354.24% [1] Group 1: Business Performance - The company achieved a significant revenue growth of 18.44% in the first half of 2025, driven by its optimized "1+3" development strategy and high R&D investment [1] - The company maintained a high gross margin of 55.67%, an increase of 1.47 percentage points compared to the same period last year, with the electronic testing instruments contributing 97% of the revenue [2] Group 2: R&D and Product Development - R&D investment reached 73.0687 million yuan in the first half of 2025, focusing on market demand and customer orientation to enhance core competitiveness [2] - New products launched during the period include a 44GHz handheld spectrum analyzer and a 41GHz handheld vector signal generator, reflecting continuous product iteration [2] Group 3: Market Opportunities - The information communication market and smart connected vehicles are expected to drive demand for communication testing equipment, with a projected compound annual growth rate of 20.6% for IoT modules from 2021 to 2026 [2] - The smart vehicle market in China is anticipated to reach 282.2 billion yuan by 2025, increasing the demand for automotive electronic testing equipment [2] Group 4: Investment Outlook - The company focuses on self-developed RF communication testing technology and overall solutions, with expected net profits of 16 million, 19 million, and 24 million yuan for 2025-2027, corresponding to P/E ratios of 221, 178, and 145 times [3] - The overall valuation of the machinery equipment industry is around 81 times, indicating that the company's valuation is relatively high, leading to a cautious recommendation [3]

Core Viewpoint - China Galaxy has issued a recommendation rating for Muyuan Foods (002714.SZ) based on strong performance indicators and growth potential [2] Group 1: Company Performance - The company is expected to see significant growth in Q2 2025, with improving gross margins [2] - In the first half of the year, the company's pig sales increased by 45% year-on-year, with the complete cost in June being below 12.1 yuan/kg [2] - The revenue from meat processing in the first half of the year rose by 94% year-on-year, with a capacity utilization rate of nearly 79% [2]

（文章来源：每日经济新闻） 中国银河8月21日发布通信设备行业研报，维持行业推荐评级。评级理由：1）支持卫星星座建设以及应 用产业规模扩展，科技引领，政策支持。2）商业航天支持政策细化，产业趋势向好。3）应用场景日渐 丰富，需求+供给共振，产业规模预计将持续高增。投资建议：建议关注商业航天快速发展机遇，个股 包括普天科技、通宇通讯、震有科技、金信诺、纵横通信、振芯科技等。风险提示：卫星行业发展不及 预期的风险；全球政治经济形势变动的风险等。 ...

Core Viewpoint - China Galaxy has issued a recommendation rating for Xilinmen (603008.SH, latest price: 18.12 yuan) based on its strong positioning in the AI product line and channel development [2] Group 1: AI Product Line - The AI product line is increasingly well-developed, establishing a new benchmark for smart sleep solutions [2] Group 2: Channel Development - Continuous deepening of channel layout, with synergistic empowerment through both online and offline channels, as well as domestic and international markets [2]